bPerformances of the Rapidec Carba NP test (bioMérieux) were evaluated for detection of all types of carbapenemases in Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. In less than 2 h after sample preparation, it showed a sensitivity and specificity of 96%. This ready-to-use test is well adapted to the daily need for detection of carbapenemase producers in any laboratory worldwide.
Multidrug resistance in Gram-negative bacteria is growing at an alarming rate (1). In this context, carbapenemase producers are becoming extremely important (2, 3). Rapid detection of carbapenemase producers provides critical information for antibiotic stewardship and rapid implementation of outbreak control measures (3).Few techniques are available for the rapid identification of carbapenemase producers (4) and include UV spectrophotometry (5), matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) technology (6-8), and molecular techniques (9-12). These techniques have overall good sensitivities and specificities but may require trained microbiologists, expensive equipment, and may be time-consuming and expensive. In addition, molecular techniques may fail to detect unknown carbapenemase genes or genes not included in the given gene panel.A rapid and biochemical detection of carbapenemase production was recently proposed, namely, the Carba NP test, which is based on the detection of the hydrolysis of the -lactam ring of imipenem (13). The Carba NP test has been extensively validated for the detection of carbapenemase producers in Enterobacteriaceae and Pseudomonas spp. (13)(14)(15)(16)(17)(18)(19)(20), and a slightly modified version of this test (CarbAcineto NP) has been developed for the detection of carbapenemase-producing Acinetobacter spp. (21). Here, we evaluated the performance of the Rapidec Carba NP test (bioMérieux, La Balme-les-Grottes, France) from bacterial cultures and compared its performance to those of the Carba NP test (13) and the CarbAcineto NP test (21).Performance of the Rapidec Carba NP test compared to that of the Carba NP test. A total of 176 strains were used to evaluate the performance of the Rapidec Carba NP test. They were from various clinical origins (blood culture, urine, sputum, gut flora), of worldwide origin, and isolated from 2010 to 2014. These strains had previously been characterized for their carbapenemase content at the molecular level (Table 1). This strain collection included the most frequently acquired carbapenemases identified worldwide, including those found in Enterobacteriaceae, Pseudomonas sp., and Acinetobacter sp. clinical isolates, and also rare carbapenemases. Susceptibility testing was performed by determining MIC values using the Etest (bioMérieux) on Mueller-Hinton agar plates at 37°C, and results were recorded according to U.S. guidelines (CLSI) as updated in 2014 (22). A total of 98 isolates producing all types of carbapenem-hydrolyzing -lactamases were included, with 75 carbapenemase-negative strains either carbapenem susceptible (...